Galderma Group N
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Galderma Group N generated cash of $139,114,632, which is more than the previous year. Cash used in financing activities reached the amount of $119,181,036 last year. Net change in cash is therefore $92,902,705.
Cash Flow
| 2022 | 106.29M | -70.48M | -68.86M |
|---|---|---|---|
| 2023 | 139.11M | -156.09M | 119.18M |
GALD.SW Cash Flow Statement (2022 – 2023)
| 2023 | 2022 | |
|---|---|---|
Cash at beginning of period | 216.44M | 259.22M |
Operating activities | ||
Net income | -48.10M | -92.54M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||
Depreciation and amortization | 248.38M | 265.22M |
Stock-based compensation expense | 0 | 0 |
| Deferred income tax benefit | 0 | 0 |
| Changes in operating assets and liabilities: | ||
Accounts receivable, net | 39.69M | -63.89M |
Inventories | 26.15M | -121.67M |
Accounts payable | 0 | 139.63M |
Cash generated by operating activities | 139.11M | 106.29M |
Investing activities | ||
Purchases Of Investments | 0 | 0 |
Investments In Property Plant And Equipment | -102.02M | -152.33M |
Acquisitions Net | -19.32M | 81.84M |
Cash generated by investing activities | -156.09M | -70.48M |
Financing activities | ||
Common Stock Issued | 908.89M | 0 |
Payments for dividends | 0 | 0 |
Repurchases of common stock | 0 | 0 |
Repayments of term debt | -731.48M | -66.66M |
Cash used in financing activities | 119.18M | -68.86M |
Net Change In Cash | 92.90M | -42.81M |
Cash at end of period | 309.34M | 216.40M |
| Data source | Data source |